FDA Inspection 986772 — Idaho Center for Reproductive Medicine
The FDA completed an inspection of Idaho Center for Reproductive Medicine on September 14, 2016 in Boise, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 14, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Boise, ID (United States)